Literature DB >> 2394899

Vision characteristics of individuals identified as Irlen Filter candidates.

M Scheiman1, P Blaskey, E B Ciner, M Gallaway, M Parisi, K Pollack, R Selznick.   

Abstract

Individuals with "scotopic sensitivity syndrome" have been reported to have visual symptoms including eye strain, headaches, blurred vision, double vision and words moving on the page. This study was designed to investigate Irlen's claims that these symptoms are unrelated to vision anomalies. She suggests that the use of Irlen tinted lenses/filters relieves these symptoms and results in improved reading performance. Thirty nine subjects (age 10-49) were recruited by advertising for a study of Irlen Filters/Lenses. Before the Irlen screening all subjects received an optometric examination. The results of this study demonstrate that 95 percent of the subjects identified as candidates for Irlen Filters did have significant and readily identifiable vision anomalies. Fifty seven percent of the subjects had received vision care within the past year, yet testing revealed that 90 percent of these subjects had significant vision problems that had not been corrected.

Entities:  

Mesh:

Year:  1990        PMID: 2394899

Source DB:  PubMed          Journal:  J Am Optom Assoc        ISSN: 0003-0244


  3 in total

1.  Effects of wearing yellow spectacles on visual skills, reading speed, and visual symptoms in children with reading difficulties.

Authors:  Catalina Palomo-Álvarez; María C Puell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-26       Impact factor: 3.117

2.  Association between reading speed, cycloplegic refractive error, and oculomotor function in reading disabled children versus controls.

Authors:  Patrick Quaid; Trefford Simpson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-29       Impact factor: 3.117

Review 3.  A systematic review of controlled trials on visual stress using Intuitive Overlays or the Intuitive Colorimeter.

Authors:  Bruce J W Evans; Peter M Allen
Journal:  J Optom       Date:  2016-07-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.